powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1376885905
Anika Anam
M.D.
Endocrinology
New Haven,
CT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
87.4
Quality
77.4
Cost
74.3
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
436
Beneficiaries
—
Total drug cost
$3.2M
Distinct drugs
10
Brand share
36.7%
Top prescribed drugs
Alendronate Sodium
145 claims
Levothyroxine Sodium
62 claims
Levothyroxine Sodium
51 claims
Abaloparatide
32 claims
Pen Needle, Diabetic
28 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
771
Unique beneficiaries
—
Total services
824
Distinct HCPCS
10
Medicare payment
$38K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 136 Endocrinology providers in CT — above median (cohort median 616).
